RUNX1 and breast cancer: Our experiments show that while AML1K83Q retains transactivation activity and contributes to a BC-like phenotype in mice, AML1R80C dominant-negatively inhibits activity of wt.AML1 but does not contribute to a BC-like phenotype in mice.